MGMT and glioblastoma: To address this question and to further investigate the role of Ape1 in alkylator resistance, we used anti-Ape1 ASO to show that suppressing Ap endo activity in the MGMT-deficient human GBM line SNB19 increased sensitivity to TMZ (Silber et al., 2002).